Pandion Therapeutics Inc Asset Turnover Ratio (PAND), as of fourth quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Pandion Therapeutics Inc   (NASDAQ: PAND)
 

Pandion Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Pandion Therapeutics Inc 's asset turnover ratio, the ratio that measures the ability of Pandion Therapeutics Inc 's assets to generate revenue, sequentially decreased to 0.04 in the fourth quarter (Dec 31 2020), but it does not raise any concerns as Pandion Therapeutics Inc continue to execute well, and the asset turnover ratio remains above the average.

Within sector Pandion Therapeutics Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2020 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PAND Asset Turnover Ratio (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
II. Quarter		 (Dec 31 2019)
IV. Quarter
Y / Y Asset Change - - - - -
Y / Y Revenue Change 126.58 % - - - -
Asset Turnover Ratio (TTM) 0.04 0.06 0.08 - -
PAND's Total Ranking # # # # #
Seq. Asset Change -5.44 % 111.83 % 168.53 % - -
Seq. Revenue Change -16.76 % 34.63 % - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




PAND Company Profile • Back to PAND Efficiency Comparisons • Compare PAND Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2020 Assets at quarter ending Dec 31 2020
Delcath Systems Inc   0.08 $ 1.646  Millions$ 20.355  Millions
Can fite Biopharma Ltd   0.08 $ 0.763  Millions$ 9.523  Millions
Aclaris Therapeutics Inc   0.08 $ 6.482  Millions$ 81.124  Millions
Talphera Inc   0.08 $ 5.416  Millions$ 69.303  Millions
Wave Life Sciences Ltd   0.08 $ 20.077  Millions$ 257.956  Millions
Zai Lab Limited  0.08 $ 48.958  Millions$ 648.158  Millions
Oncternal Therapeutics Inc   0.08 $ 3.375  Millions$ 44.756  Millions
Shattuck Labs Inc   0.07 $ 9.934  Millions$ 134.734  Millions
Arbutus Biopharma Corp  0.07 $ 6.914  Millions$ 94.963  Millions
Fresh Tracks Therapeutics Inc   0.07 $ 1.822  Millions$ 25.126  Millions
Sorrento Therapeutics Inc   0.07 $ 39.986  Millions$ 551.882  Millions
Spero Therapeutics Inc   0.07 $ 9.330  Millions$ 129.483  Millions
Bicycle Therapeutics Plc  0.07 $ 10.390  Millions$ 144.774  Millions
Avricore Health Inc   0.07 $ 0.025  Millions$ 0.345  Millions
Orgenesis Inc   0.07 $ 7.652  Millions$ 108.710  Millions
Scholar Rock Holding Corp  0.07 $ 15.403  Millions$ 220.947  Millions
Fulcrum Therapeutics Inc   0.07 $ 8.823  Millions$ 127.878  Millions
Cogent Biosciences Inc   0.07 $ 7.871  Millions$ 115.195  Millions
Arvinas Inc   0.07 $ 25.900  Millions$ 383.587  Millions
Zymeworks Inc   0.07 $ 38.951  Millions$ 588.382  Millions
Oramed Pharmaceuticals Inc  0.07 $ 2.710  Millions$ 41.326  Millions
Beone Medicines Ltd   0.06 $ 308.874  Millions$ 4,784.412  Millions
Kazia Therapeutics Limited  0.06 $ 0.995  Millions$ 15.897  Millions
Deciphera Pharmaceuticals Inc   0.06 $ 42.087  Millions$ 680.333  Millions
Northwest Biotherapeutics Inc  0.06 $ 1.291  Millions$ 21.050  Millions
Ac Immune Sa  0.06 $ 16.452  Millions$ 270.037  Millions
Five Prime Therapeutics Inc   0.06 $ 13.178  Millions$ 220.087  Millions
Endonovo Therapeutics Inc   0.06 $ 0.166  Millions$ 2.825  Millions
Taiwan Liposome Company Ltd   0.06 $ 3.630  Millions$ 62.303  Millions
Fate Therapeutics Inc   0.06 $ 31.434  Millions$ 556.096  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.